TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: In conclusion, TRPM3 dysfunction in post-COVID-19 condition and ME/CFS participants suggests impairment in ion mobilization and consequently results in Ca2+ signaling and cell homeostasis disturbance in both diseases.